首页 › 公司 › KNTE
Kinnate Biopharma Inc.（KNTE）高管持股异动
该公司内部人(高管 / 董事 / 10% 以上股东)向 SEC 申报的交易记录。
完整申报记录(含历史)
本站从 SEC EDGAR 收录的历史 Form 4 申报(共 82 条)。此区为完整数据档案,与上方带中文解读的精选申报分开呈现。
| 申报日 | 申报人 | 表单 | 类型 | 金额 | 净股数 |
|---|---|---|---|---|---|
| 2024-04-05 | Foresite Capital Opportunity Fund V, L.P. | 4 | 回售予公司 | — | -1371.8 万股 |
| 2024-04-05 | Dean J Mitchell | 4 | 回售予公司 | — | — |
| 2024-04-05 | Helen Sabzevari | 4 | 回售予公司 | — | — |
| 2024-04-05 | Nima Farzan | 4 | 回售予公司 | — | -2,186 股 |
| 2024-04-05 | Jill Desimone | 4 | 回售予公司 | — | — |
| 2024-04-05 | Michael E Rome | 4 | 回售予公司 | — | — |
| 2024-04-05 | Neha Krishnamohan | 4 | 回售予公司 | — | -6.4 万股 |
| 2024-04-05 | Mark A Meltz | 4 | 回售予公司 | — | -2.8 万股 |
| 2024-04-05 | Keith T. Flaherty | 4 | 回售予公司 | — | -6.6 万股 |
| 2024-04-05 | OrbiMed Asia GP IV, L.P. | 4 | 回售予公司 | — | -801.0 万股 |
| 2024-04-05 | Melissa B, Epperly | 4 | 回售予公司 | — | — |
| 2024-04-05 | Carl L Gordon | 4 | 回售予公司 | — | -801.0 万股 |
| 2024-04-05 | James B. Tananbaum | 4 | 回售予公司 | — | -1371.8 万股 |
| 2024-04-05 | Alsup Laurie Smaldone | 4 | 回售予公司 | — | — |
| 2024-03-05 | Neha Krishnamohan | 4 | 缴税代扣股份 | $3,901 | -1,506 股 |
| 2024-03-05 | Richard Thomas Williams | 4 | 缴税代扣股份 | $1,445 | -558 股 |
| 2024-03-05 | Mark A Meltz | 4 | 缴税代扣股份 | $1,445 | -558 股 |
| 2023-12-05 | Richard Thomas Williams | 4 | 缴税代扣股份 | $1,217 | -541 股 |
| 2023-12-05 | Neha Krishnamohan | 4 | 缴税代扣股份 | $3,283 | -1,459 股 |
| 2023-12-05 | Mark A Meltz | 4 | 缴税代扣股份 | $1,217 | -541 股 |
| 2023-09-06 | Richard Thomas Williams | 4 | 缴税代扣股份 | $1,271 | -541 股 |
| 2023-09-06 | Neha Krishnamohan | 4 | 缴税代扣股份 | $3,429 | -1,459 股 |
| 2023-09-06 | Mark A Meltz | 4 | 缴税代扣股份 | $1,271 | -541 股 |
| 2023-06-13 | Alsup Laurie Smaldone | 4 | 获授予/取得 | — | — |
| 2023-06-13 | Carl L Gordon | 4 | 获授予/取得 | — | — |
| 2023-06-13 | Dean J Mitchell | 4 | 获授予/取得 | — | — |
| 2023-06-13 | Keith T. Flaherty | 4 | 获授予/取得 | — | — |
| 2023-06-13 | Melissa B, Epperly | 4 | 获授予/取得 | — | — |
| 2023-06-13 | Helen Sabzevari | 4 | 获授予/取得 | — | — |
| 2023-06-05 | Neha Krishnamohan | 4 | 缴税代扣股份 | $6,274 | -1,459 股 |
| 2023-06-05 | Richard Thomas Williams | 4 | 缴税代扣股份 | $2,326 | -541 股 |
| 2023-06-05 | Mark A Meltz | 4 | 缴税代扣股份 | $2,326 | -541 股 |
| 2023-05-10 | James B. Tananbaum | 4 | 公开市场买入 | $498.4 万 | 178.0 万股 |
| 2023-05-10 | Foresite Capital Management IV, LLC | 4 | 公开市场买入 | $498.4 万 | 178.0 万股 |
| 2023-05-08 | ORBIMED ADVISORS LLC | 4 | 公开市场买入 | $408.6 万 | 146.1 万股 |
| 2023-05-08 | Carl L Gordon | 4 | 公开市场买入 | $408.6 万 | 146.1 万股 |
| 2023-05-02 | OrbiMed Capital GP VII LLC | 4 | 公开市场买入 | $367.4 万 | 140.5 万股 |
| 2023-05-02 | Carl L Gordon | 4 | 公开市场买入 | $367.4 万 | 140.5 万股 |
| 2023-03-03 | Jill Desimone | 4 | 获授予/取得 | — | — |
| 2023-03-03 | Richard Thomas Williams | 4 | 缴税代扣股份 | $3,324 | -638 股 |
| 2023-03-03 | Mark A Meltz | 4 | 缴税代扣股份 | $3,324 | -638 股 |
| 2023-03-03 | Neha Krishnamohan | 4 | 缴税代扣股份 | $8,966 | -1,721 股 |
| 2023-02-23 | OrbiMed Genesis GP LLC | 4 | 获授予/取得 | — | 110.0 万股 |
| 2023-02-22 | Carl L Gordon | 4 | 获授予/取得 | — | 110.0 万股 |
| 2023-02-22 | Foresite Capital Management IV, LLC | 4 | 其他方式取得/处置 | — | 110.0 万股 |
| 2023-02-22 | James B. Tananbaum | 4 | 其他方式取得/处置 | — | 110.0 万股 |
| 2023-02-15 | Nima Farzan | 4/A | 获授予/取得 | — | — |
| 2023-02-14 | Nima Farzan | 4 | 获授予/取得 | — | — |
| 2023-02-14 | Mark A Meltz | 4 | 获授予/取得 | — | — |
| 2023-02-14 | Richard Thomas Williams | 4 | 获授予/取得 | — | — |
| 2023-02-14 | Neha Krishnamohan | 4 | 获授予/取得 | — | — |
| 2022-12-02 | Richard Thomas Williams | 4 | 缴税代扣股份 | $4,193 | -541 股 |
| 2022-12-02 | Neha Krishnamohan | 4 | 缴税代扣股份 | $1.1 万 | -1,459 股 |
| 2022-12-02 | Mark A Meltz | 4 | 缴税代扣股份 | $4,193 | -541 股 |
| 2022-09-02 | Mark A Meltz | 4 | 获授予/取得 | — | 2.5 万股 |
| 2022-09-02 | Richard Thomas Williams | 4 | 获授予/取得 | — | 2.5 万股 |
| 2022-09-02 | Neha Krishnamohan | 4 | 获授予/取得 | — | 6.8 万股 |
| 2022-06-15 | Helen Sabzevari | 4 | 获授予/取得 | — | — |
| 2022-06-15 | James B. Tananbaum | 4 | 获授予/取得 | — | — |
| 2022-06-15 | Keith T. Flaherty | 4 | 获授予/取得 | — | — |
| 2022-06-15 | Alsup Laurie Smaldone | 4 | 获授予/取得 | — | — |
| 2022-06-15 | Carl L Gordon | 4 | 获授予/取得 | — | — |
| 2022-06-15 | Michael E Rome | 4 | 获授予/取得 | — | — |
| 2022-06-15 | Dean J Mitchell | 4 | 获授予/取得 | — | — |
| 2022-06-15 | Melissa B, Epperly | 4 | 获授予/取得 | — | — |
| 2022-03-15 | Richard Thomas Williams | 4 | 公开市场买入 | $33.9 万 | 4.0 万股 |
| 2022-02-15 | Carl L Gordon | 4 | 公开市场买入 | $198.9 万 | 19.6 万股 |
| 2022-02-15 | Mark A Meltz | 4 | 获授予/取得 | — | — |
| 2022-02-15 | OrbiMed Genesis GP LLC | 4 | 公开市场买入 | $198.9 万 | 19.6 万股 |
| 2022-02-15 | Neha Krishnamohan | 4 | 获授予/取得 | — | — |
| 2022-02-15 | Nima Farzan | 4 | 获授予/取得 | — | — |
| 2022-02-15 | Richard Thomas Williams | 4 | 获授予/取得 | — | — |
| 2021-06-28 | Helen Sabzevari | 4 | 获授予/取得 | — | — |
| 2021-06-14 | Keith T. Flaherty | 4 | 获授予/取得 | — | — |
| 2021-06-14 | Alsup Laurie Smaldone | 4 | 获授予/取得 | — | — |
| 2021-06-14 | Melissa B, Epperly | 4 | 获授予/取得 | — | — |
| 2021-06-14 | Dean J Mitchell | 4 | 获授予/取得 | — | — |
| 2021-06-08 | Neha Krishnamohan | 4 | 获授予/取得 | — | — |
| 2021-02-16 | Richard Thomas Williams | 4 | 获授予/取得 | — | — |
| 2021-02-16 | Mark A Meltz | 4 | 获授予/取得 | — | — |
| 2021-02-16 | Nima Farzan | 4 | 获授予/取得 | — | — |
| 2021-02-16 | Eric Anthony Murphy | 4 | 获授予/取得 | — | — |
历史档案为按 SEC 数据集批量收录的申报记录,未逐条生成中文解读;金额 / 净股数由申报字段派生。完整原文以 SEC EDGAR 为准。
说明:此处的「内部人交易 / 高管持股异动」指公司内部人依法向 SEC 提交的 Form 3/4/5 持股披露,是合法的公开申报,
与「内幕交易」(利用未公开重大信息牟利的违法行为)是两回事,请勿混淆。